http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112017005238-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a7ac31dafa9b644bcbf73f79c4695dc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
filingDate 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9fe0865ae109ed5f72fd22638f5a684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246ca55c93d485836c21a2a9263dbf87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a2b4656aaed8d5f5612cdcd19c8e0ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2839922fb36d710b016b79ecc6bfb838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1ec585b45b04a3b115d571545923ef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a106027e38831524f3ffe1d396ab1a61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87916c663a49e66c48781c81086359f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b86c85cdf0d89a53f128f7e5bcac1e12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae7d67ec83fc03efede2476226d6efb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aea1e785634eb0095603912cffce6bb
publicationDate 2023-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112017005238-B1
titleOfInvention PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES, THEIR USE AND PHARMACEUTICAL COMPOSITION
abstract The invention relates to inhibitors of mutant isocitrate dehydrogenase proteins (mt-IDH) with useful neomorphic activity in the treatment of cell proliferation disorders and cancers, having Formula: (I), in which A, U, W1, W2, W3 , R1-R6 and R9 are described herein.
priorityDate 2014-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID945702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID938183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157215070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID888013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID841875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447675208
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42586

Total number of triples: 40.